Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Tevogen Bio Holdings ( (TVGN) ) has provided an announcement.
On June 23, 2025, Tevogen Bio Holdings Inc. held its Annual Meeting of Stockholders, where a quorum was achieved with 167,360,586 shares represented. During the meeting, stockholders elected Jeffrey Feike and Dr. Curtis Patton as Class I directors for a three-year term and ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
The most recent analyst rating on (TVGN) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Tevogen Bio Holdings stock, see the TVGN Stock Forecast page.
Spark’s Take on TVGN Stock
According to Spark, TipRanks’ AI Analyst, TVGN is a Underperform.
Tevogen Bio Holdings faces substantial financial risks due to consistent losses and high leverage, which are typical in its industry. Technical analysis indicates a bearish trend, and valuation metrics show speculative investment characteristics. However, the recent corporate event involving a strategic agreement provides a positive outlook for operational advancements, slightly balancing the financial and technical concerns.
To see Spark’s full report on TVGN stock, click here.
More about Tevogen Bio Holdings
Average Trading Volume: 971,803
Technical Sentiment Signal: Sell
Current Market Cap: $220.7M
For an in-depth examination of TVGN stock, go to TipRanks’ Overview page.